Clinical Trial Update: Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This study evaluates neoadjuvant accelerated short-course radiation therapy with proton beam therapy plus capecitabine for resectable pancreatic cancer; Phase 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-01-23